Skip to main content
Clinical Trials/NCT01732432
NCT01732432
Withdrawn
Not Applicable

Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) - Epidemiological and Molecular Pathological Aspects

University Hospital, Basel, Switzerland0 sitesOctober 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endometrioid Carcinoma
Sponsor
University Hospital, Basel, Switzerland
Primary Endpoint
incidence and clinical outcome of endometriosis-associated ovarian carcinomas
Status
Withdrawn
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine whether a relationship exists between a previously established diagnosis of endometriosis and the consecutive risk of developing a clear cell or endometrioid ovarian carcinoma. All histopathological records since 1980 with these diagnoses (endometriosis, clear cell and endometrioid ovarian carcinoma) will be reviewed. Cancer registry data will be assessed to investigate differences in survival of women with endometriosis-associated ovarian carcinomas and those ovarian carcinoma patients without previous diagnosis of endometriosis.

Registry
clinicaltrials.gov
Start Date
October 2012
End Date
December 2013
Last Updated
11 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • endometrioid ovarian carcinoma
  • clear cell ovarian carcinoma
  • endometriosis, atypical endometriosis
  • borderline tumors with endometriosis

Exclusion Criteria

  • undifferentiated carcinomas
  • germ cell tumors
  • sex cord-stromal tumors

Outcomes

Primary Outcomes

incidence and clinical outcome of endometriosis-associated ovarian carcinomas

Time Frame: 30 years

Similar Trials